Clearstead Advisors’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1K Buy
536
+6
+1% +$133 ﹤0.01% 1946
2026
Q1
$12.3K Sell
530
-500
-49% -$15.6K ﹤0.01% 1547
2025
Q4
$45.6K Buy
1,030
+320
+45% +$18K ﹤0.01% 1442
2025
Q3
$51.9K Buy
710
+45
+7% +$2.93K ﹤0.01% 1269
2025
Q2
$40.8K Buy
665
+320
+93% +$17.9K ﹤0.01% 1349
2025
Q1
$20K Sell
345
-38
-10% -$2.4K ﹤0.01% 1424
2024
Q4
$20.4K Buy
383
+220
+135% +$10.8K ﹤0.01% 1383
2024
Q3
$7.1K Buy
163
+100
+159% +$3.33K ﹤0.01% 1652
2024
Q2
$1.76K Sell
63
-204
-76% -$5.38K ﹤0.01% 1831
2024
Q1
$6.14K Hold
267
﹤0.01% 1146
2023
Q4
$7.49K Buy
+267
New +$6.31K ﹤0.01% 1105
2022
Q1
Sell
-86
Closed -$4K 1394
2021
Q4
$4K Buy
86
+2
+2% +$130 ﹤0.01% 1017
2021
Q3
$7K Buy
+84
New +$6.14K ﹤0.01% 983

Other funds holding DOCS

Clearstead Advisors's DOCS Position: Q2 2026 in Review

Clearstead Advisors increased its Doximity (DOCS) stake by 1.1% in Q2 2026, buying an estimated $133 and bringing the position to 536 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1946.

Clearstead Advisors first reported a position in DOCS in Q3 2021 and has held it in 13 quarters since. The position peaked at $51.9K in Q3 2025. 162 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Clearstead Advisors held 536 shares of Doximity worth $11.1K as of Q2 2026.
  • Clearstead Advisors bought 6 Doximity shares in Q2 2026, an estimated $133.
  • Doximity made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1946 holding.
  • Clearstead Advisors first reported a position in Doximity in Q3 2021 and has held it in 13 quarters since.
  • Clearstead Advisors's Doximity position peaked at $51.9K in Q3 2025.
  • 162 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.